Flagship Harbor Advisors, LLC Seagen Inc. Transaction History

Flagship Harbor Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$135.08 - $161.1 $210,319 - $250,832	-1,557 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$137.51 - $190.8 $114,545 - $158,936	-833 Reduced 34.85%	1,557 $216,000
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $393,465 - $506,512	2,390 New	2,390 $419,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.